The Conolidine Diaries
Our profiling and comparison of the steps of conolidine and cannabidiol with acknowledged pharmacological agents predicted a MOA shared with Cav2.two channel blocker, ω-conotoxin CVIE.Exploration on conolidine is restricted, but the handful of studies available present that the drug holds assure for a possible opiate-like therapeutic for Long-term